Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Change in Working Capital (2015 - 2026)

Cellectis (CLLS) posted quarterly Change in Working Capital of -$19.5 million for Q1 2026, down 195.99% year-over-year from $20.3 million in Q1 2025, and down 151.97% quarter-over-quarter from $37.5 million in Q4 2025.

Analysis

Cellectis (CLLS) Change in Working Capital (2015 - 2026) Analysis & Trends

Cellectis' Change in Working Capital history runs 12 years deep, the most recent figure standing at -$19.5 million for Q1 2026.

  • In Q1 2026, Change in Working Capital fell 195.99% year-over-year to -$19.5 million; the TTM figure through Mar 2026 stood at $28.7 million (up 165.23% YoY), while the FY2025 annual figure was $41.6 million, up 177.5% from the prior year.
  • Change in Working Capital for Q1 2026 stood at -$19.5 million, down from $37.5 million in the prior quarter.
  • The five-year high for Change in Working Capital was $70.1 million in Q4 2022, with the low at -$22.2 million in Q1 2022.
  • The 5-year median for Change in Working Capital is -$16.0 million (2023), against an average of -$4.4 million.
  • The sharpest annual moves came in 2024 and 2025: Change in Working Capital plunged 606.61% in 2024, then jumped 426.92% in 2025.
  • Cellectis' Change in Working Capital stood at $70.1 million in 2022, then slumped by 94.22% to $4.1 million in 2023, then slumped by 606.61% to -$20.5 million in 2024, then surged by 282.66% to $37.5 million in 2025, then plunged by 151.97% to -$19.5 million in 2026.
  • Business Quant data shows CLLS's Change in Working Capital at -$19.5 million in Q1 2026, $37.5 million in Q4 2025, and $17.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cellectis 321.90 Mn 155.05 Mn - -17.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.29 Mn
Mar 31, 2026 -19.50 Mn
Dec 31, 2025 -10.30 Mn
Sep 30, 2025 16.96 Mn
Jun 30, 2025 -6.31 Mn
Mar 31, 2025 -6.59 Mn
Dec 31, 2024 -4.11 Mn
Sep 30, 2024 -5.19 Mn
Jun 30, 2024 -11.65 Mn
Mar 31, 2024 -16.29 Mn
Dec 31, 2023 -20.67 Mn
Sep 30, 2023 -18.69 Mn
Jun 30, 2023 -18.20 Mn
Mar 31, 2023 -16.03 Mn
Dec 31, 2022 146,000.00
Sep 30, 2022 -20.90 Mn
Jun 30, 2022 -21.32 Mn
Mar 31, 2022 -22.21 Mn
Dec 31, 2021 17.76 Mn
Sep 30, 2021 -29.67 Mn